Big Pharma

KEI Leaks TPP Text On Intellectual Property

August 4, 2015 James Love, www.keionline.org Resist! Big Pharma, health, Health Care, TPP, Trade

By James Love of Knowledge Ecology International. Washington, DC - Today, August 4, 2015, Knowledge Ecology International (KEI) released text from three sections of the 95-page secret negotiating text on the Intellectual Property Chapter being used in the Trans-Pacific Partnership Agreement (TPP, sometimes referred to as TPPA) trade negotiations. The negotiating text is dated May 11, 2015, and reflects the state of the text right before the Maui rounds of the negotiation, which ended Friday, July 31, 2015. Analysis and more text to be forthcoming.

Leaked: What’s In Obama’s TPP Trade Deal

July 2, 2015 Michael Grunwald, www.politico.com Educate! Big Pharma, Capitalism, Public Health, TPP

By Michael Grunwald in Politico - A recent draft of the Trans-Pacific Partnership free-trade deal would give U.S. pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in U.S. law. The draft text includes provisions that could make it extremely tough for generics to challenge brand-name pharmaceuticals abroad. Those provisions could also help block copycats from selling cheaper versions of the expensive cutting-edge drugs known as “biologics” inside the U.S., restricting treatment for American patients while jacking up Medicare and Medicaid costs for American taxpayers. “There’s very little distance between what Pharma wants and what the U.S. is demanding,” said Rohit Malpini, director of policy for Doctors Without Borders.

Leaked Text Shows Big Pharma Using TPP Against Global Health

June 11, 2015 Deirdre Fulton, www.commondreams.org Educate! Big Pharma, Finance and the Economy, Free Trade, Public Health, TPP

By Deirdre Fulton in Common Dreams - Bolstering long-held criticisms from public interest groups, newly leaked sections of the Trans-Pacific Partnership (TPP) show how Big Pharma is employing "an aggressive new form of transnational corporatism" to increase profits at the expense of global health. The TPP's "Healthcare Annex"—which seeks to regulate government policies around medicines and medical devices—would give big pharmaceutical companies more power over public access to medicine while crippling public healthcare programs around the world and "tying the hands" of the U.S. Congress in its ability to pursue Medicare reform and lower drug costs. President Barack Obama is trying to gain Fast Track approval from the U.S. House of Representatives as early as tomorrow, having already obtained it from the Senate, which would grant him increased power to push the TPP and other mammoth trade pacts through Congress.

Peruvian Patients Reject TPP: Will Affect Their Access To Medication

October 22, 2014 Rael Mora, www.telesurtv.net Educate! Big Pharma, Finance and the Economy, Peru, TPP

Leaks on the secret trade agreement, the TPP, are worrying social organizations that deal with health issues in Peru. They predict that the adoption of such a treaty will result in many deaths. On Monday, after the release of new information by Wikileaks, social organizations defending the interests of health patients have spoken out against the TPP. Representatives from the Peruvian Network for Patients and Users claim the treaty will allow for pharmaceutical companies to dominate the use of a drug for decades. The Trans Pacific-Partnership agreement (TPP) is a free trade agreement that is being negotiated in secret by 12 countries including Peru. One of the most controversial aspects of the treaty is the one that protects medicine patents, benefiting the interests of large pharmaceutical companies.

Big Ag’s Big Lie: Factory farms, Your Health and the New Politics of Antibiotics

January 13, 2014 Alexander Zaitchik, www.salon.com Educate! Big Pharma, FDA, Food and Agriculture, Monsanto

The new guidelines, known as Final Guidance 213, were officially released two weeks ago, just in time for Christmas. “Two-thirteen is an early holiday gift to industry,” says Avinash Kar, a health attorney at the Natural Resources Defense Council. “The FDA has essentially followed a voluntary approach for more than 35 years, but use of these drugs to raise animals has increased. There’s no reason why voluntary recommendations will make a difference now, especially when FDA’s policy covers only some of the many uses of antibiotics on animals that are not sick.”

«1 2 3 4 5 6 »

Daily movement news and resources